CGP 51901

Drug Profile

CGP 51901

Alternative Names: AL 901; Antiallergy MAb

Latest Information Update: 14 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tanox
  • Class Antiallergics; Monoclonal antibodies
  • Mechanism of Action Immunoglobulin inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Seasonal allergic rhinitis

Most Recent Events

  • 22 Jun 1999 Tanox Biosystems is now called Tanox
  • 19 Oct 1998 Suspended-I for Seasonal allergic rhinitis in United Kingdom (Unknown route)
  • 19 Oct 1998 Suspended-II for Asthma in United Kingdom (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top